B3GALT5-AS1 directly bound to the promoter of miR-203, repressed miR-203 expression, upregulated miR-203 targets ZEB2 and SNAI2, and induced EMT, suggesting that downregulated B3GALT5‐AS1 is a biomarker of CRC metastasis and, more importantly, activating B3GALT5-AS1/miR-203/EMT axis may be a potential therapeutic strategy for CRLM.233 Recently, B3GALT5‐AS1 has been reported to be related to TNM stage and histological differentiation.234 There are also other lncRNA that regulated CRLM through ceRNA mode, for example MALAT1, SNHG14, SNHG7, H19, and LINC00485. The gene discussed is MALAT1; the disease is colorectal carcinoma.